📰 Leukemia News
Page 129 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
March 20, 2023
The experimental menin inhibitor revumenib led to "deep and sustained remission" for two genetic subtypes of aggressive relapsed/refractory acute leukemia in the first-in-human trial.
March 19, 2023
♪ ♪ every night, even when my heart was sad, i wished for you to sign up. ♪ i got so sick that i couldnt go to school, but i still made people laugh. ♪ but when we matched, it was the best day ever. dear donor, your blood stem cells saved me from leukemia. ♪ thank you forever and ever and ever. sincerely, owen. ♪ experience the true joy of saving a life at bethematch.org.
March 17, 2023
With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the treatment of AML has been available for several years. But for some patients, the drug combination does not work.
March 16, 2023
Revumenib sheds light on AML patients as the drug potentially treats their cancer. A group of researchers conducted phase one of clinical trials between 2019 to 2022 for an anti-cancer drug on patients living with acute myeloid leukemia (AML).
March 16, 2023
About a third of patients with relapsed or refractory acute leukemia experienced complete remission after taking the drug, known as revumenib.
March 15, 2023
Consuming a diet rich in vitamin A or its analogs may help prevent children and young adults with acute lymphoblastic leukemia (ALL) reduce their risk of developing painful pancreas inflammation during chemotherapy treatment.
March 15, 2023
A new approach that delivers a "one-two punch" to help T cells attack solid tumors is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania.
March 14, 2023
Unlike other forms of blood cancer, acute myeloid leukemia (AML) cannot currently be treated with CAR-T cell immunotherapy.
March 13, 2023
The blood thinner Eliquis from Bristol Myers Squibb, Pfizers breast cancer drug Ibrance and AbbVies leukemia treatment Imbruvica are likely to be among 10 big-selling medicines subject to U.S.... | March 13, 2023
March 8, 2023
A relentless blood cancer claimed the lives of her loved ones, and she's fighting to save lives in spite of it.